Cronos makes and sells cannabis and hemp products, from dried flower to wellness creams, under brands like Spinach and Lord Jones.
Revenue is small (USD 0.15B in 2025) and mostly from cannabis sales; gross margin is 45%, but net income swings wildly, so no steady profit engine yet.
Brands like Spinach and Lord Jones have some recognition, but cannabis is commoditized and competitors like Canopy Growth and Tilray can easily match products.
Key events, in time order
None yet
None yet
A stock analysis platform added a write-up on $CRON, indicating a focus on its earnings potential. The discussion appears to be a fundamental thesis on the stock.
Main discussion
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
